Functional Genomics for Cancer Drug Target Discovery

被引：49

作者：

Haley, Benjamin ^{[1
]}

Roudnicky, Filip ^{[2
]}

机构：

[1] Genentech Inc, Mol Biol Dept, 1 DNA Way, San Francisco, CA 94080 USA

[2] F Hoffmann La Roche Ltd, Roche Innovat Ctr Basel, Pharmaceut Res & Early Dev, CH-4070 Basel, Switzerland

来源：

CANCER CELL | 2020年 / 38卷 / 01期

关键词：

LARGE-SCALE; SYNTHETIC LETHALITY; CRISPR-CAS9; SCREENS; GENE ESSENTIALITY; RNAI; SHRNA; GUIDE; IDENTIFICATION; CRISPR/CAS9; MUTAGENESIS;

D O I：

10.1016/j.ccell.2020.04.006

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Functional genomics describes a field of biology that uses a range of approaches for assessing gene function with high-throughput molecular, genetic, and cellular technologies. The near limitless potential for applying these concepts to study the activities of all genetic loci has completely upended how today's cancer biologists tackle drug target discovery. We provide an overview of contemporary functional genomics platforms, highlighting areas of distinction and complementarity across technologies, so as to aid in the development or interpretation of cancer-focused screening efforts.

引用

页码：31 / 43

页数：13

共 50 条

[41] Use of Computational Functional Genomics in Drug Discovery and Repurposing for Analgesic Indications
Loetsch, Joern
Kringel, Dario
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2018, 103 (06) : 975 - 978
[42] Search for increased efficiency in drug discovery motivates functional genomics growth
不详
PHARMACOGENOMICS, 2002, 3 (06) : 733 - 733
[43] Functional genomics shifts drug discovery paradigm to protein expression & separation
Glaser, V
GENETIC ENGINEERING NEWS, 1997, 17 (15): : 1 - &
[44] Data integration and graph analysis for cancer genomics and drug discovery
Bernard, B.
Miller, M.
Rovira, H.
Shmulevich, I.
EUROPEAN JOURNAL OF CANCER, 2014, 50 : 90 - 90
[45] Structural genomics and drug discovery
Edwards, A
Berman, J
Sundstrom, M
ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 40, 2005, 40 : 349 - 369
[46] The impact of genomics on drug discovery
Debouck, C
Metcalf, B
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 2000, 40 : 193 - 207
[47] Impact of genomics in drug discovery
Ward, SJ
BIOTECHNIQUES, 2001, 31 (03) : 626 - +
[48] Protozoan genomics for drug discovery
Chaudhary, K
Roos, DS
NATURE BIOTECHNOLOGY, 2005, 23 (09) : 1089 - 1091
[49] Structural genomics and drug discovery
Lundstrom, K.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2007, 11 (02) : 224 - 238
[50] Genomics and antimicrobial drug discovery
Moir, DT
Shaw, KJ
Hare, RS
Vovis, GF
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (03) : 439 - 446

← 1 2 3 4 5 →